East Hanover, NJNCT07786077Now EnrollingIRB Ready

Primary Immune Thrombocytopenia Clinical Trial in East Hanover, NJ

Access cutting-edge primary immune thrombocytopenia treatment through this clinical trial at a research site in East Hanover. Study-provided care at no cost to qualified participants.

Sponsored by Novartis Pharmaceuticals

Quick Self-Assessment

See if you qualify for this East Hanover location

Preparing your pre-screening questions…

Expert Care in East Hanover

Access primary immune thrombocytopenia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related primary immune thrombocytopenia treatment provided free

Apply for This East Hanover Location

Check if you qualify for this primary immune thrombocytopenia clinical trial in East Hanover, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to East Hanover

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit East Hanover site if eligible
  4. 4Begin participation

About This Primary Immune Thrombocytopenia Study in East Hanover

This study aims to evaluate treatment preferences of patients with Primary Immune Thrombocytopenia (ITP) in the United States (US) by conducting a preference elicitation survey.

Sponsor: Novartis Pharmaceuticals

Who Can Participate

Inclusion Criteria

Currently living in the US.
Aged 18 years and older on the day of providing informed consent.
A diagnosis of primary ITP: a. For participants receiving first-line (1L) treatment for ITP: i. Diagnosed with primary ITP and started 1L corticosteroids within 3 months of diagnosis ii. Responded to 1L corticosteroid treatment \[with or without intravenous immunoglobulin (IVIg)\] b. For participants receiving second-line (2L) treatment for ITP: i. Assessed as needing or are taking thrombopoietin receptor agonist (TPO-RA) treatment for 2L treatment ii. Has previously been treated with a 1L corticosteroid (with or without IVIg) with insufficient response or relapse

Exclusion Criteria

For participants receiving 1L treatment for ITP only: Previous or current use of treatments different from corticosteroids and/or IVIg/anti-D immunoglobulin.
For participants receiving 2L ITP treatment: Previous or current use of treatments different from corticosteroids, IVIg/anti-D immunoglobulin or one TPO-RA (i.e. patients who have used any treatment in a third-line setting are ineligible).

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in East Hanover?

Yes, this clinical trial (NCT07786077) has an active research site in East Hanover, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Primary Immune Thrombocytopenia Treatment Options in East Hanover, NJ

If you're searching for primary immune thrombocytopenia treatment options in East Hanover, NJ, this clinical trial (NCT07786077) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our East Hanover research site is actively enrolling participants for this clinical trial. You'll receive care from experienced primary immune thrombocytopenia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all primary immune thrombocytopenia clinical trials near you to find additional studies recruiting in your area.

More Multiple Myeloma Trials in East Hanover, NJ

See all multiple myeloma clinical trials recruiting in East Hanover — not just this study.

Browse Multiple Myeloma Trials in East Hanover →

Browse More Trials by Condition

Multiple Myeloma TrialsPulmonary Embolism TrialsThrombocytopenia TrialsIdiopathic Thrombocytopenic Purpura TrialsAll Conditions →

Ready to Join in East Hanover?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · East Hanover, NJ